Wockhardt Limited (NSE:WOCKPHARMA)

India · Delayed Price · Currency is INR

1,886.30

+55.70 (3.04%)

Aug 21, 2026, 3:30 PM IST

Wockhardt Earnings Call Transcripts

Fiscal Year 2026

Status update
The group has transformed into an innovation-led healthcare company, achieving strong financial growth and launching Zaynich, a novel antibiotic with global potential. Zaynich targets resistant infections, with a robust U.S. and India launch strategy, and aims for $1.5–$2 billion peak annual sales.

Read full transcript →

Slides